本页面由Tiger Trade Technology Pte. Ltd.提供服务

Kiniksa Pharmaceuticals Ltd.

79.24
-0.5400-0.68%
盘后:79.240.00000.00%19:30 EDT
成交量:34.09万
成交额:2,716.71万
市值:61.83亿
市盈率:80.04
高:80.99
开:80.00
低:78.82
收:79.78
52周最高:82.94
52周最低:35.20
股本:7,802.40万
流通股本:3,994.15万
量比:0.86
换手率:0.85%
股息:- -
股息率:- -
每股收益(TTM):0.9900
每股收益(LYR):0.7500
净资产收益率:14.04%
总资产收益率:8.05%
市净率:9.45
市盈率(LYR):105.65

数据加载中...

2026/09/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/30

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/29

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/28

重要事件披露

Form 8-K - Current report
2026/05/29

重要事件披露

Form 8-K - Current report
2026/05/26

重要事件披露

Form 8-K - Current report
2026/05/06

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/01

重要事件披露

Form 8-K - Current report
2026/04/28

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/28

重要事件披露

Form 8-K - Current report
2026/04/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities